CClinicalTrials.gg
Sign In
Status unknownNCT02659189Updated Aug 13, 2019

Hospitalary Chronic Obstructive Pulmonary Disease Registry

An observational study in COPD Exacerbations and Death, sponsored by Hospital Italiano de Buenos Aires. Status unknown at 1 site in Argentina. Open to participants aged 40 Years to 85 Years. Per ClinicalTrials.gov, last updated 2019-08-13.

Sponsored by Hospital Italiano de Buenos Aires · Observational

The sponsor has not verified this record recently (last verified Aug 2019), so the status shown — last known as Recruiting — may be out of date.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
300
Ages
40 Years to 85 Years
Sex
All
01

Study summary

The purpose of this study is to create an institutional registry of Chronic Obstructive Pulmonary disease through a prospective survey based on epidemiological data, risk factors, diagnosis, prognosis, treatment, monitoring and survival.

Read the detailed description

The main goal is to describe the characteristics of chronic obstructive pulmonary disease patients, including their clinical, spirometric, exacerbation and mortality characteristics within the population of the Hospital Italiano de Buenos Aires.

02

Conditions studied

  • COPD Exacerbations
  • Death
03

In context

Lung Diseases, Obstructive

2,592 studies on the registry are indexed under Lung Diseases, Obstructive; 198 are open to participants now.

This study's planned enrollment of 300 is above the median of 150 across 639 observational studies indexed under Lung Diseases, Obstructive.

Browse Lung Diseases, Obstructive studies →

Lead sponsor

Hospital Italiano de Buenos Aires is the lead sponsor of 128 studies on the registry; 23 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
40 Years to 85 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Patients older than 40 years with a chronic obstructive pulmonary disease diagnosis according to global initiative for chronic obstructive lung disease criteria.

Inclusion criteria

  • Patients older than 40 years with a chronic obstructive pulmonary disease diagnosis according to global obstructive lung Global initiative for chronic Obstructive Lung Disease criteria.
  • Follow up at the Hospital Italiano de Buenos Aires.

Exclusion criteria

Exclusion Criteria:

  • Refusal to participate or to agree to the informed consent.
  • Known non chronic obstructive pulmonary disease respiratory disease (ej: Lung Cancer, Tuberculosis, Pulmonary Fibrosis, Neumoconiosis, Cystic Fibrosis, Sarcoidosis, etc)
  • Severe alpha-1 antitripsin deficit (typr SZ or ZZ)
  • Previously thoracic surgery (ej: lung volume reduction, lung transplantation).
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
300 participants (estimated)
Target follow-up
3 Years
Patient registry
Yes
06

What researchers measure

Primary outcomes

  1. Death

    All cause of death

    Time frame: At 6 months after enrollment

Secondary outcomes

  1. Morbidity

    Saint George respiratory questionnaire

    Time frame: At 6 months after enrollment

  2. Functional decline (Forced expired volume at one second)

    Forced expired volume at one second

    Time frame: At 12 months after enrollment

  3. Exacerbations (defined as an increase in symptoms that requires treatment)

    Number of exacerbations in the timeframe (defined as an increase in symptoms that requires treatment)

    Time frame: At 12 months after enrollment

07

Study locations

1 of 1 sites recruiting
08

References and documents

Publications

  • Muiño Adriana, María Victoria López Varela, and Ana María Menezes. Prevalencia de la enfermedad pulmonar obstructiva crónica y sus principales factores de riesgo: proyecto platino en Montevideo. Revista Médica del Uruguay. 2005;21: 37-48
  • Moreira GL, Gazzotti MR, Manzano BM, Nascimento O, Perez-Padilla R, Menezes AM, Jardim JR. Incidence of chronic obstructive pulmonary disease based on three spirometric diagnostic criteria in Sao Paulo, Brazil: a nine-year follow-up since the PLATINO prevalence study. Sao Paulo Med J. 2015 May-Jun;133(3):245-51. doi: 10.1590/1516-3180.2015.9620902. Epub 2015 Jun 1. PubMed 26176929 ↗

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 13, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02659189
Lead sponsor
Hospital Italiano de Buenos Aires
Responsible party
Sponsor
First posted
Jan 20, 2016
Start date
Jul 2016
Primary completion
Dec 2019 (estimated)
Completion
Jan 2020 (estimated)
Last update
Aug 13, 2019

Study contacts

Diego H Giunta, MD
Contact
diego.giunta@hospitalitaliano.org.ar
541149590200 ext. 4806
Diego H Giunta, MD
principal investigator · Hospital Italiano de Buenos Aires

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Aug 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies in this condition

Lung Diseases, Obstructive→

Other studies from this sponsor

Hospital Italiano de Buenos Aires

Start the discussion